Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zevra Therapeutics (ZVRA) Intangibles: 2023-2024

Historic Intangibles for Zevra Therapeutics (ZVRA) over the last 2 years, with Dec 2024 value amounting to $69.0 million.

  • Zevra Therapeutics' Intangibles fell 90.46% to $6.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.7 million, marking a year-over-year decrease of 90.46%. This contributed to the annual value of $69.0 million for FY2024, which is 0.34% down from last year.
  • Zevra Therapeutics' Intangibles amounted to $69.0 million in FY2024, which was down 0.34% from $69.2 million recorded in FY2023.
  • Zevra Therapeutics' Intangibles' 5-year high stood at $69.2 million during FY2023, with a 5-year trough of $69.0 million in FY2024.
  • Moreover, its 2-year median value for Intangibles was $69.1 million (2023), whereas its average is $69.1 million.
  • Data for Zevra Therapeutics' Intangibles shows a maximum YoY dropped of 0.34% (in 2024) over the last 5 years.
  • Yearly analysis of 2 years shows Zevra Therapeutics' Intangibles stood at $69.2 million in 2023, then decreased by 0.34% to $69.0 million in 2024.